BridgeMD
New treatment option for Obsessive Compulsive Disorder (OCD)
Official title Gamified Combined Cognitive Bias Modification in Adults Diagnosed With OCD: Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06941155
What this study is testing
- What it's testing
- This randomized controlled trial examines the effects of a mobile-based gamified combined cognitive bias modification (CBM-C) intervention on obsessive-compulsive symptoms, obsessive beliefs, attentional and interpretation biases, depressive symptoms, and psychological distress. The gamified CBM-C condition is compared to a standard mobile-based CBM-C and a placebo control condition.
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age 18 years or older
- Primary diagnosis of obsessive-compulsive disorder (OCD), confirmed by a licensed clinician using the Structured Clinical Interview for DSM-5 (SCID-5)
- No current suicidal ideation or psychotic symptoms
- Access to the internet and a mobile phone
- Stable psychiatric medication use for at least one month prior to enrollment, with no changes in dosage during the 4-week intervention period
You likely can't join if
- Presence of active suicidal ideation or psychotic symptoms
- Unstable psychiatric medication use (e.g., recent dose change within the past month or expected change during the intervention period)
- Significant neurological or medical illness that may interfere with participation
- Visual impairments that would prevent accurate perception of colored stimuli (e.g., color blindness)
- Current participation in another clinical trial involving psychological intervention
- Receiving concurrent psychotherapy or other psychological treatments outside of the study
See the full eligibility criteria
- Age 18 years or older
- Primary diagnosis of obsessive-compulsive disorder (OCD), confirmed by a licensed clinician using the Structured Clinical Interview for DSM-5 (SCID-5)
- No current suicidal ideation or psychotic symptoms
- Access to the internet and a mobile phone
- Stable psychiatric medication use for at least one month prior to enrollment, with no changes in dosage during the 4-week intervention period
- No current neurological or medical condition that would interfere with participation
- Ability to perceive colored visual stimuli (e.g., no color blindness)
- Not currently enrolled in another intervention-based study
- Not receiving any other form of psychological treatment at the time of participation
- Presence of active suicidal ideation or psychotic symptoms
- Unstable psychiatric medication use (e.g., recent dose change within the past month or expected change during the intervention period)
- Significant neurological or medical illness that may interfere with participation
- Visual impairments that would prevent accurate perception of colored stimuli (e.g., color blindness)
- Current participation in another clinical trial involving psychological intervention
- Receiving concurrent psychotherapy or other psychological treatments outside of the study
The study team makes the final eligibility decision.
Where it's taking place
- Izmir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Izmir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.